Rilpivirine versus efavirenz in HIV-1-infected subjects receiving emtricitabine/tenofovir DF: pooled 96-week data from ECHO and THRIVE Studies. Nelson MR et al, HIV Clin Trials. 2013 May-Jun;14(3):81-91 Posted on July 8th, 2013 - Pr Pedro Cahn Back to Home page
Back to Home page